《大行報告》花旗下調中車時代電氣(03898.HK)目標價至35元 評級「沽售」
花旗發表報告指,雖然中車時代電氣(03898.HK)(688187.SH)的A股已於今年9月7日上市,但相信股份面對的威脅仍未完全消除,主因其IGBT(絕緣柵雙極晶體管)業務估值對該行而言依然太貴。
花旗下調中車時代電氣股份目標價,由38元降至35元,以反映A股IPO後的股份稀釋,投資評級則維持「沽售」。該行又輕微調升集團明年及2023年的盈利預測各2%,主因對IGBT業務的預測上調。不過,由於A股上市對盈利的稀釋,今年至2023年每股盈利預測分別調低5%、16%及16%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.